Cytodyn Inc (CYDY)

[moneycrew]

Oh Phil? Oh yeah so back in January he stated and asked:

The product at issue is a drug (not approved yet, still in clinics trials). The name of the drug is leronlimab, formerly pro-140. On August 17th, 2020, Cytodyn released a PR stating that the company had filed for Emergency Use Authorization (EUA) with the FDA for the COVID19 mild to moderate population using the data from their completed COVID19 M2M trial (CD10_COVID-19 or NCT04343651). I have reason to believe that Cytodyn misled investors and that the company did not file an EUA for the M2M indication. If possible, I would like a copy of the EUA filed by Cytodyn or if that?s not an option, an acknowledgment from the FDA that the organization either received the EUA from Cytodyn or that you didn?t receive the EUA.

Hmmmmmmmmm, this is part of what's being looked at???